Pierluigi Paracchi

Verkställande Direktör på GENENTA SCIENCE S.P.A.

Förmögenhet: 2 M $ per 2026-05-31

52 år

16 relationer

Health Technology

Finance

Consumer Services

Profil

Pierluigi Paracchi was the founder of Xyence Capital SGR SpA, founded in 2003, where the title held was Chief Executive Officer from 2009 to 2011.
Mr. Paracchi is the founder of Genenta Science SpA, founded in 2014, holding the title of Chairman & Chief Executive Officer starting in 2024.
Mr. Paracchi is the founder of Aurora-TT Srl, founded in 2017, with the title of Venture Consultant starting in 2017.
Mr. Paracchi is also the founder of Aurora Science Srl..
Mr. Paracchi is Chairman & Chief Executive Officer at Praexidia Industrie Strategiche SpA starting in 2025.
Mr. Paracchi is Director at Assobiotec starting in 2019.
Mr. Paracchi is Director at Altheia Science Srl.
Former positions include Non-Executive Chairman at Lipogems International SpA, Director at EOS SpA, and Venture Partner at Axon Partners Group Investment SGEIC SA. Education includes undergraduate studies at Università Cattolica del Sacro Cuore Campus di Milano.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
GENENTA SCIENCE SPA 12,64 %	2026-03-30	2 302 516 ( 12,64 % )	2 M $	2026-05-31

Aktiva positioner av Pierluigi Paracchi

Företag	Position	Start
GENENTA SCIENCE S.P.A.	Verkställande Direktör	2014-07-24
Aurora-TT Srl Aurora-TT Srl Investment ManagersFinance Aurora-TT is an active manager which invests in Italian startups . The firm invests in pre-seed to early stage in the health technology sector with particular preference for biotechnology and pharmaceuticals.	Grundare	2017-01-01
Altheia Science Srl Altheia Science Srl Pharmaceuticals: MajorHealth Technology Develop treatment and resolving medicines for auto-immune diseases, focusing on multiple sclerosis and diabetes	Direktör/Styrelseledamot	-
Assobiotec Assobiotec Miscellaneous Commercial ServicesCommercial Services Operates as professional association for the development of biotechnology	Direktör/Styrelseledamot	2019-05-15

Alla aktiva positioner av Pierluigi Paracchi

Tidigare kända positioner av Pierluigi Paracchi

Företag	Position	Slut
Xyence Capital SGR SpA Xyence Capital SGR SpA Investment ManagersFinance Xyence Capital invests in startup companies located in europe the United States and Italy. The firm targets companies operating in the field of electronic and health technology sector with particular focus in biotechnology and IT services. It provides equity for early to later stage as well as growth capital requirements with invests between EUR 0.5 to EUR 24 million.	Grundare	2011-02-01
Axon Partners Group Investment SGEIC SA Axon Partners Group Investment SGEIC SA Investment ManagersFinance Axon Partners Group invests in lower to middle market companies located in Spain, Italy, Latin America and Europe. The firm focuses on climate technology, infrastructure, B2B and B2C sectors. It provides financing in early, secondary and growth stage transactions. The firm also acquires minority interests.	Privat kapitalinvesterare	-
Lipogems International SpA Lipogems International SpA Medical SpecialtiesHealth Technology Manufactures and supplies medical devices	Ordförande	-
Aurora Science Srl Aurora Science Srl Investment ManagersFinance Functions as a venture capital fund	Grundare	-
EOS SpA EOS SpA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products	Direktör/Styrelseledamot	-

Se detaljerna i Pierluigi Paracchis erfarenhet

Pierluigi Paracchis utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Pierluigi Paracchis erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	10
Università Cattolica del Sacro Cuore Campus di Milano Università Cattolica del Sacro Cuore Campus di Milano Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Axon Partners Group Investment SGEIC SA Axon Partners Group Investment SGEIC SA Investment ManagersFinance Axon Partners Group invests in lower to middle market companies located in Spain, Italy, Latin America and Europe. The firm focuses on climate technology, infrastructure, B2B and B2C sectors. It provides financing in early, secondary and growth stage transactions. The firm also acquires minority interests.	Finance
EOS SpA EOS SpA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products	Health Technology
Xyence Capital SGR SpA Xyence Capital SGR SpA Investment ManagersFinance Xyence Capital invests in startup companies located in europe the United States and Italy. The firm targets companies operating in the field of electronic and health technology sector with particular focus in biotechnology and IT services. It provides equity for early to later stage as well as growth capital requirements with invests between EUR 0.5 to EUR 24 million.	Finance
Assobiotec Assobiotec Miscellaneous Commercial ServicesCommercial Services Operates as professional association for the development of biotechnology	Commercial Services
Genenta Science SpA Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors	Health Technology
Lipogems International SpA Lipogems International SpA Medical SpecialtiesHealth Technology Manufactures and supplies medical devices	Health Technology
Altheia Science Srl Altheia Science Srl Pharmaceuticals: MajorHealth Technology Develop treatment and resolving medicines for auto-immune diseases, focusing on multiple sclerosis and diabetes	Health Technology
Aurora-TT Srl Aurora-TT Srl Investment ManagersFinance Aurora-TT is an active manager which invests in Italian startups . The firm invests in pre-seed to early stage in the health technology sector with particular preference for biotechnology and pharmaceuticals.	Finance
Aurora Science Srl Aurora Science Srl Investment ManagersFinance Functions as a venture capital fund	Finance